The Innate Killer Summit 2017 is dedicated to help you take critical steps to enhance your biological understanding, ensure successful translation and effective clinical development of natural killer, NKT & γδ T cell immunotherapies.
Access exclusive, cutting-edge data and the latest clinical progress needed to implement a best practice approach to progress your natural killer, NKT & γδT cell pipeline with a forward-looking plan for global manufacture and distribution to patients in need. Capitalize on more robust allogeneic development approaches and overcome safety concerns experienced by other cell therapies.
“This meeting will be one of the first opportunities to bring together the leading Innate Killer Cell companies in a focused setting." - Fortress Biotech